« Back to Record
Scaltriti., M., Parra, J. L., Prudkin, L., Molina Jimenez, J., Aura, C. M., Harbeck, N., Pusztai, L., Ellis, C., Eidtmann, H., Arribas, J., Cortes, J., Nuciforo, P. G., de Azambuja, E., Piccart-Gebhart, M., Baselga, J., Bradbury, I., Sperinde, J., Agbor‑Tarh, D., Campbell, C., Chenna, A., Winslow, J., & Serra, V. (2015). High HER2 expression correlates with response to the combination of lapatinib and trastuzumab. Clinical cancer research, 21(3), 569-576. doi:10.1158/1078-0432.CCR-14-1824
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/231595



